Novo CEO pressed by Senate to cut costs of obesity, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the company would take into account new talks with insurers about the record prices of Wegovy and copyright whenever they pledge to help keep the medicines on their formularies. Will not miss https://cesarulbri.blogtov.com/11101195/5-simple-techniques-for-healthcare-news